Schedule 13G ownership disclosure

Mirum Pharmaceuticals Inc

Common Stock, par value $0.0001 per share · CUSIP: 604749101

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BIOTECHNOLOGY VALUE FUND L P

    Shares: 772,595.00 · Class: 1.5%

  • BVF I GP LLC

    Shares: 772,595.00 · Class: 1.5%

  • BIOTECHNOLOGY VALUE FUND II LP

    Shares: 610,666.00 · Class: 1.2%

  • BVF II GP LLC

    Shares: 610,666.00 · Class: 1.2%

  • Biotechnology Value Trading Fund OS LP

    Shares: 82,238.00 · Class: 0.2%

  • BVF Partners OS Ltd.

    Shares: 82,238.00 · Class: 0.2%

  • BVF GP HOLDINGS LLC

    Shares: 1,383,261.00 · Class: 2.8%

  • BVF PARTNERS L P/IL

    Shares: 1,495,290.00 · Class: 3.0%

  • BVF INC/IL

    Shares: 1,495,290.00 · Class: 3.0%

  • LAMPERT MARK N

    Shares: 1,495,290.00 · Class: 3.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-25-003107
Form type
SCHEDULE 13G/A
Filer
BIOTECHNOLOGY VALUE FUND L P
CIK
CIK 918923
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub